Latest KFF Health News Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Abbott’s Fast COVID Test Poses Safety Issues, Lab Workers Say
HHS said this test would “save personal protective equipment.” But Abbott’s very design ― devised for mobile testing — means those working with specimens need even more protection, experts warn.
Amid Pandemic, FDA Seizes Cheaper Drugs From Canada
Many Americans order drugs from Canada and other countries because they are cheaper, but U.S. authorities appear to be cracking down on the practice.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
KHN’s ‘What The Health?’: How Will We Reopen The Economy?
The politics of COVID-19 are pretty polarized, but health experts across the ideological spectrum agree: The U.S. will need more robust testing before it’s safe to relax social-distancing requirements. Meanwhile, President Donald Trump, Congress and the nation’s governors continue to spar over who should be responsible for what. Kimberly Leonard of Business Insider, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.
A Desperate Scramble As COVID-19 Families Vie For Access To Plasma Therapy
As efforts ramp up to collect blood plasma from the first survivors of COVID-19, families of critically ill patients are jockeying to obtain the still-unproven antibody treatment.
‘You Pray That You Got The Drug.’ Ailing Couple Gambles On Trial For COVID-19 Cure
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
Trump Touted Abbott’s Quick COVID-19 Test. HHS Document Shows Only 5,500 Are On Way For Entire U.S.
States urgently need millions of tests, and the game changer they’ve been waiting on falls well short of what is needed, according to government documents obtained by KHN.
Falsas promesas de curas, tratamientos y pruebas caseras para COVID-19 por internet
Pruebas no aprobadas por la FDA y varios informes cuestionables de Internet relacionados con pruebas de coronavirus, vacunas y curas “milagrosas” han estado circulando por las redes sociales.
Online Coronavirus Tests Are Just The Latest Iffy Products Marketed To Anxious Consumers
Americans are worried about the novel coronavirus, so they are turning to the internet for solutions to stem their fears. Buyer, beware. It could be dangerous.
¿Por qué lleva tanto tiempo? Cómo es el paso a paso de una prueba para COVID-19
Desde la toma de la muestra con un hisopo hasta el paso final, expertos explican cómo se trata la muestra para COVID-19, y explican futuros tests rápidos que podrían arrojar un resultado en minutos.
What Takes So Long? A Behind-The-Scenes Look At The Steps Involved In COVID-19 Testing
A common complaint about the testing process is the long turnaround time for results.
As Coronavirus Testing Gears Up, Specialized Swabs Running Out
Nationwide, testing for coronavirus is ramping up. But the supply of specialty swabs needed to collect potential coronavirus specimens can’t keep up with demand, creating a bottleneck in testing capabilities. So two top manufacturers are working with U.S. and Italian governments to increase production.
Estos científicos crearon rápido una prueba eficaz mientras el coronavirus se acercaba
Los doctores Keith Jerome y Alex Greninger, de la Universidad de Washington, han supervisado la implementación de más de 4,000 pruebas de pacientes de todo el país.
How Intrepid Lab Sleuths Ramped Up Tests As Coronavirus Closed In
Drs. Keith Jerome and Alex Greninger fast-tracked a test for the deadly new coronavirus weeks before it began spreading in the U.S. Their work has been key to detecting community transmission and ramping up the nation’s testing capacity.
Call For FDA To Withdraw Preterm Birth Drug Divides Doctors and Insurers
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.
In-Home Teeth-Straightening Business Is Booming ― But Better Brace Yourself
SmileDirectClub and similar startup companies say they provide these services at what can be thousands of dollars less than office-visit teeth straightening, but proof is lacking and patients can be left with no recourse if problems arise.
Team Trump Says Administration’s Action On Health Care ‘Is Working.’ Is It?
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
KHN’s ‘What The Health?’: Democrats Roll Dice On SCOTUS And The ACA
A group of Democratic state attorneys general are betting the Supreme Court will take up the case and overturn a federal appeals court ruling in time for the 2020 elections. In other high-court news, most Republicans in Congress are asking the justices to use a Louisiana law to overturn the landmark abortion-rights ruling, Roe v. Wade. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss this and more. Rovner also interviews NPR’s Richard Harris, who wrote the latest KHN-NPR “Bill of the Month” feature.
A Reality Check On Artificial Intelligence: Are Health Care Claims Overblown?
As happens when the tech industry gets involved, hype surrounds the claims that artificial intelligence will help patients and even replace some doctors.
